FREE Daily Stock Alerts From Stock-PR.com
Thwapr, Inc. (OTC.BB:THWI), a service for mobilizing and monetizing branded video content, today announced the roll out of an important new way for marketers to measure the success of their mobile video campaigns. Thwapr's new Analytics Dashboard provides extensive tracking and measurement of mobile video and SMS analytics with graphical charts and graphs that illustrate campaign successes and opportunities.
Measuring mobile campaigns is key in demonstrating success and ROI for marketers, said Bruce Goldstein, CEO, Thwapr. We can help them see in real-time, how their mobile videos are performing and exactly how and when they are engaging with their audience.
To view the Dashboard, marketers log in to a secure, custom branded Web portal to view mobile video statistics and analytic data which is updated dynamically and accessible at anytime. Key analytics and features in the Dashboard include:
Topline Statistics A summary of total mobile video subscribers, video views and uploads, and SMS messages distributed for full campaign period; date range search option for ad-hoc queries by day(s), week(s), month(s), etc.
Content statistics Graphical bar chart view of the most popular videos (30+ displayed); statistics for individual videos shown by title and identifier with respect to video views, video Twitter posts, and mobile videophone sharing (30+ displayed); date range search option for ad-hoc queries by day(s), week(s), month(s), etc.
Mobile Device and Carrier Statistics Graphical bar chart view of the most popular mobile devices (20+ displayed); statistics for the most popular mobile devices accessed by users (20+ displayed); graphical pie chart view of the most popular Tier 1 & Tier 2 carriers (US/Canada); date range search option for ad-hoc queries by day(s), week(s), month(s), etc.
Subscriber Statistics Graphical bar chart view of opt-in and opt-out mobile video SMS statistics; statistics for subscription (total and daily opt-in and opt-out, absolute and %); date range search option for ad-hoc queries by day(s), week(s), month(s), etc.
Thwapr customer the NFL's Miami Dolphins, uses the mobile video sharing platform to connect daily with the team's fan base. The Analytics Dashboard allows the Dolphins to track important metrics about the sign up and viewing habits of their fans.
We have found the Dashboard to be a key tool for understanding the type of content our fans want to see more of, said Scott Stone, senior director of Internet and Publications for the Miami Dolphins. We can determine the best time of day to send team videos so we achieve the best sign-up rates and engagement with our fans.
The Miami Dolphins are among other professional sports, music and entertainment brands to utilize Thwapr's mobile video sharing including the NHL's Phoenix Coyotes, the Vans Warped Tour®, the Rockstar Energy Drink Mayhem Festival® and the Lordz of Brooklyn, among others.
About Thwapr, Inc.
Founded in 2007, Thwapr is a mobile video sharing service that allows brands to mobilize and monetize content, extending its distribution reach while delivering the highest possible quality and user experience regardless of device, network or carrier. Founded by digital video pioneers from Apple, Avid and MTV, Thwapr's patent-pending Share to Phone technology is revolutionizing mobile video, while also revitalizing traditional media by incorporating branded mobile video into print, broadcast, billboards and radio. A cloud-based solution that does not require a download or app, Thwapr is making mobile video sharing easy, fast and fun for the hundreds of millions of consumers with Web-enabled mobile devices. For more information about Thwapr, please go to http://corp.thwapr.com, visit Thwapr at www.twitter.com/thwapr or become a fan at www.facebook.com/thwapr.
Power3 Medical Products, Inc. (PWRM.OB)
Power3 Medical Products, Inc. (OTC.BB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced that company management believes it is making great progress in its focus on the development, sales, and marketing of its proprietary innovate diagnostic tests for breast cancer, pancreatic cancer, ovarian cancer, colon cancer, and certain neurodegenerative diseases, such as Alzheimer's and Parkinson's, to name a few.
In addition, Power3 is a party to several litigation matters, most of which relate to various toxic debt instruments that were entered into by Power3 several years ago when it operated under the tenure of Chairman and CEO, Steven B. Rash. Because current management believes these toxic debt instruments are responsible for Power3's depressed stock price and have distracted the company from its mission, Power3 plans to settle as many of these nagging lawsuits as possible prior to the completion of its merger with Rozetta-Cell Life Sciences, Inc. As for those lawsuits that cannot be speedily resolved, Power3 will continue to rigorously defend its position. For example, one such lawsuit involves Neogenomics, Inc., which was recently granted a motion for summary judgment with respect to an amount due under a convertible debenture. Power3 intends to appeal this decision.
We are very excited to be finally ridding ourselves of litigation that has plagued us for several years now, stated Ira L. Goldknopf, President and Chief Scientific Officer of Power3 Medical Products, Inc. We have big plans for the future beginning with our upcoming acquisition of Rozetta-Cell and are about to enter a long and substantial growth phase marked by advances in our science and intellectual property. Given the imminent nature of many of these transactions and breakthroughs, we have decided, in consultation with the financiers of Rozetta-Cell, that the best course of action for Power3 is to settle many of these lawsuits so that we can focus our attention exclusively on the acquisition of Rozetta-Cell and the development of our combined businesses after the merger.
Rozetta-Cell Life Sciences, Inc. is a medical biotechnology company that focuses on the delivery and imaging of stem cells during therapy. Power3 plans to effect the acquisition of Rozetta-Cell by merging Rozetta-Cell with and into Power3, with Power3 remaining as the surviving company. The acquisition of Rozetta-Cell is expected to be completed in February 2011.
Parkinson's disease typically has effects on people around fifty. The early signs of PD tend to be subtle and also occur gradually. When it comes to many people the condition moves along more rapidly than in others. The fact that the condition moves along, the shaking, or tremor, which will has an effect on nearly all PD individuals may turn to restrict every day actions. Other signs and symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been which can support in diagnosing sporadic PD. For that reason the medical diagnosis is determined by track record and a neurological examination. The illness can be tough to diagnose precisely. Physicians may very well sometimes demand brain scans or laboratory tests in order to exclude other diseases.
Alzheimer's disease (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia belonging to the Alzheimer's type (PDDAT), or Alzheimer's-is often the most typical kind of dementia. This particular incurable, degenerative, and deadly condition was first explained German professional and neuropathologist Alois Alzheimer in 1906 and even was referred to as after him. Generally, it really is determined in individuals over 65 years of age, however the less-prevalent early-onset Alzheimer's may appear much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer's is usually expected to influence 1 in 85 people today throughout the world by the year 2050.
International, breast cancer consists 10% of all cancer incidence among the ladies, defining it as the most frequent kind of non-skin cancer in females and also the 5th most popular grounds for cancer death. In 04, cancer of the breast caused 519,000 fatalities world-wide (7% associated with cancer deaths; almost 1% of all deaths). Cancer of the breast is about a hundred times more established in women compared to men, although men are apt to have poorer success on account of waiting times in medical diagnosis.
Quest Diagnostics Inc. (NYSE:DGX) the world's leading provider of diagnostic testing, information and services, announced that it will report fourth quarter and full year 2010 results and provide financial guidance for 2011 on Tuesday, January 25, before the market opens. It will hold its quarterly conference call with investors to discuss the results beginning at 8:30 a.m. ET on that day. The public may access the conference call through a live audio webcast available on Quest Diagnostics' Investor Relations internet site at www.QuestDiagnostics.com/investor. The conference call can also be accessed in listen-only mode by dialing 415-228-4961, passcode 3214469.
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally.
Axis Capital Holdings Ltd. (NYSE:AXS) will hold a conference call to discuss financial results for the fourth quarter and year ended December 31, 2010 on Wednesday, February 9, 2011, at 9:00am ET, which is one hour later than its originally-scheduled time. As previously announced, the Company plans to release its financial results on Tuesday, February 8, 2011, after the close of the financial markets. The teleconference can be accessed by dialing (866) 843-0890 (U.S. callers) or (412) 317-9250 (international callers) and entering the passcode 5-3-8-7-6-5-5 approximately ten minutes in advance of the call. A live, listen-only webcast of the call will also be available via the Investor Information section of the Company's website at www.axiscapital.com.
AXIS Capital Holdings Limited, through its subsidiaries, provides various insurance and reinsurance products to insureds and reinsureds worldwide. It operates in two segments, Insurance and Reinsurance.
Flowserve Corp. (NYSE:FLS) a leading provider of flow control products and services for the global infrastructure markets, announced the schedule for its Analyst Day on Thursday, January 27, 2011. The event is scheduled to start at 9:00 a.m. (ET) with Flowserve senior management presentations. The event concludes at approximately 12:00 p.m. A live audio webcast of the Flowserve Analyst Day presentations, along with the corresponding slides, will be available in the Investor Relations section of the Flowserve website at http://www.flowserve.com. Flowserve Corp. is one of the world's leading providers of fluid motion and control products and services. Operating in more than 55 countries, the company produces engineered and industrial pumps, seals and valves as well as a range of related flow management services.
Flowserve Corporation develops, manufactures, and sells precision-engineered flow control equipment, as well as provides a range of aftermarket equipment services.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received five thousand dollars in cash from a third party (Mohamad Nehmeh) for one (1) week of advertisement services for Thwapr, Inc. (THWI.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Sign Up For Free Stock Alerts At http://stock-pr.com/signup
The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.